Assetta, Inc. and Lyra Strategics LLC Announce Strategic Partnership to Provide Critical Intellectual Property Services to Early-Stage Life Sciences Companies

 

Chicago, IL, August 16, 2024. Assetta, Inc., a leading provider of global intellectual property services, and Lyra Strategics LLC, renowned for excellence in patent strategy, prior-art searches, and IP portfolio development, are pleased to announce a strategic partnership aimed at providing services for early-stage/startup companies, particularly in the life sciences area, to address the critical need of protecting and managing worldwide intellectual property rights, which are vital to enterprises entering international markets.

In today’s increasingly globalized era, this collaboration brings together Assetta’s worldwide network and expertise in global IP protection and management and Lyra Strategics’ innovative solutions in Life-Sciences and Biotechnology. By leveraging the strengths of both companies, the partnership aims to deliver enhanced value to customers and drive growth in the early-stage/startup life sciences market.

 

Key Points of the Partnership:

1. Customer-Centric Approach: Combining Assetta’s customer-centric approach with Lyra Strategics’ technological advancements, the partnership aims to prioritize exceptional customer service by addressing client needs promptly and ensuring satisfaction at every touchpoint.
2. Innovation and Development:The partnership will focus on joint market research and development initiatives to create cutting-edge solutions that address the evolving needs of the client.
3. Commitment to Quality: Maintain the highest standards in all products and services, ensuring that our partnership consistently delivers reliable and superior outcomes.
4. Affordability Without Compromise: Offer competitive pricing strategies that make quality accessible, ensuring that customers receive excellent value without sacrificing quality.

 

“We are thrilled to partner with Lyra Strategics,” said Thomas Stiebel, CEO of Assetta. “This collaboration is a significant step forward in our mission to provide innovative and high-quality solutions to our customers. By combining our strengths, we are confident that we can achieve remarkable results and drive growth in the life sciences industry.”

Lyra Strategics’ CEO, Asmita Kulkarni, also expressed enthusiasm about the partnership. “Joining forces with Assetta aligns perfectly with our strategic goals. Together, we can push the boundaries of innovation and deliver exceptional value to our clients. We look forward to a successful partnership.”

By partnering with Assetta and Lyra Strategics, biotechnology companies can benefit from these two firm’s deep industry expertise, experience in IP protection, streamlined worldwide IP filing services, access to capital and licensing opportunities, and strategic insights, all of which contribute to successfully bringing innovations to market.

The partnership is effective immediately, and both companies are committed to working closely together to achieve their shared objectives.

Further details about the collaboration will be announced in the coming months.

 

About Assetta

Assetta is a leading provider of global intellectual property services, dedicated to assisting companies overcome the difficulties of implementing a global IP strategy through competitive pricing and top-quality service. With a focus on early-stage/startup life science companies, Assetta delivers high-quality solutions that meet the needs of its diverse clientele, where the protection and management of foreign-related intellectual property rights have become vital issues that enterprises must confront when entering international markets and building a global footprint.

For more information, visit www.assettaglobal.com.

 

About Lyra Strategics

Lyra Strategics is a boutique consulting firm that specializes in patent strategy, prior-art consulting services, quantitative analysis, and business development and facilitation. With expertise in patentability and freedom-to-operate analysis, Lyra Strategics ensures that biotechnology companies can protect their proprietary technology from being copied or used without permission—crucial for maintaining a competitive edge and securing the future of their innovations.

Attracting investment is another critical challenge for biotechnology companies, and Lyra Strategics addresses this by offering data-driven business strategy services. These services help companies present a compelling case to potential investors, including venture capitalists, investors, and pharmaceutical companies, increasing their chances of securing the necessary funding to bring their innovations to market.

In addition to investment support, Lyra Strategics also facilitates licensing and commercialization opportunities. By assisting with IP filing and ensuring patents are properly managed, the firm helps biotechnology companies leverage their intellectual property for revenue generation and market entry.

Finally, staying current with emerging trends in the rapidly evolving life sciences industry is essential for success. Lyra Strategics provides expert insights into dynamic sectors, helping biotechnology companies stay ahead of the curve and capitalize on new opportunities.

For more information, visit www.lyrastr.com.

 

Media Contacts:

Ben Li

Business Development Director

Assetta, Inc.

+1 (312) 792-8442

bli@assettaglobal.com

 

Asmita Kulkarni

Founder and Chief Executive Officer

Lyra Strategics LLC

+1 (404) 883-9448

asmita@lyrastr.com